Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouse

Current therapies that target vascular endothelial growth factor (VEGF) have become a mainstream therapy for the management of diabetic macular oedema. The treatment involves monthly repeated intravitreal injections of VEGF inhibitors. VEGF is an important growth factor for many retinal cells, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hombrebueno, Jose R., Ali, Imran HA., Xu, Heping, Chen, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680939/
https://www.ncbi.nlm.nih.gov/pubmed/26671074
http://dx.doi.org/10.1038/srep18316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680939/
https://www.ncbi.nlm.nih.gov/pubmed/26671074
http://dx.doi.org/10.1038/srep18316

Ejemplares similares